Stereotaxis (STXS) Return on Capital Employed (2011 - 2026)
Stereotaxis (STXS) posted quarterly Return on Capital Employed of 73.75% for Q1 2026, up 4416.0% year-over-year from 1.63% in Q1 2025, and up 11.42% quarter-over-quarter from 83.26% in Q4 2025.
Stereotaxis (STXS) Return on Capital Employed (2011 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Return on Capital Employed for 16 consecutive years, with 73.75% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed rose 4416.0% year-over-year to 73.75%; the TTM figure through Mar 2026 stood at 73.75% (up 4416.0% YoY), while the FY2025 annual figure was 81.51%, up 2740.0% from the prior year.
- Return on Capital Employed grew to 73.75% in Q1 2026 per STXS's latest filing, from 83.26% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 32.38% in Q1 2022 and bottomed at 117.9% in Q1 2025.
- Historically, Return on Capital Employed has averaged 73.18% across 5 years, with a median of 73.75% in 2026.
- Annual changes were most pronounced in 2025 — Return on Capital Employed sank 4256 bps — and 2026, when it jumped 4416 bps.
- Stereotaxis' Return on Capital Employed stood at 46.41% in 2022, then plunged by 57 bps to 72.87% in 2023, then slipped by 25 bps to 90.86% in 2024, then rose by 8 bps to 83.26% in 2025, then gained by 11 bps to 73.75% in 2026.
- Business Quant data shows STXS's Return on Capital Employed at 73.75% in Q1 2026, 83.26% in Q4 2025, and 104.69% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.28% |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | -73.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.75% |
| Dec 31, 2025 | -83.26% |
| Sep 30, 2025 | -104.69% |
| Jun 30, 2025 | -105.23% |
| Mar 31, 2025 | -117.90% |
| Dec 31, 2024 | -90.86% |
| Sep 30, 2024 | -98.52% |
| Jun 30, 2024 | -85.20% |
| Mar 31, 2024 | -75.34% |
| Dec 31, 2023 | -72.87% |
| Sep 30, 2023 | -62.87% |
| Jun 30, 2023 | -58.08% |
| Mar 31, 2023 | -53.73% |
| Dec 31, 2022 | -46.41% |
| Sep 30, 2022 | -43.28% |
| Jun 30, 2022 | -39.72% |
| Mar 31, 2022 | -32.38% |
| Dec 31, 2021 | -26.74% |
| Sep 30, 2021 | -23.40% |
| Jun 30, 2021 | -17.16% |